joyjac
★    

Philippines,
2011-07-05 09:53
(5461 d 07:41 ago)

Posting: # 7207
Views: 6,251
 

 EMA: Two-Stage design [Two-Stage / GS Designs]

Hi colleagues,

The EMEA guideline states that it is acceptable to use a two-stage approach when attempting to demonstrate bioequivalence. Can anyone enlighten me on this kind of study design, steps to be taken, stopping criteria or can we automatically switch to stage 2 if the BE fails at stage 1? Thanks and regards.


Edit: Category changed. [Helmut]
Helmut
★★★
avatar
Homepage
Vienna, Austria,
2011-07-05 21:38
(5460 d 19:57 ago)

@ joyjac
Posting: # 7211
Views: 5,144
 

 EMA: Two-Stage design

Dear Joy,

EMA does not specify a particular method. One of them (Potvin et al. 2008) we have discussed numerous times in the forum. See e.g. this post.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,571 registered users;
183 visitors (0 registered, 183 guests [including 12 identified bots]).
Forum time: 17:35 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5